China’s rapidly expanding pharmaceutical industry is pivoting from producing drugs that imitate to those that set agendas.
Focal Point Feature
Global biopharmaceutical company Henlius aims to greatly improve patient well-being with affordable and innovative biologic medicines
A Chinese pharmaceutical company is raising the bar for pharmaceutical safety and efficacy, while diversifying new research and shaping the industry ecosystem.
A carbohydrate-based Alzheimer’s drug from marine algae and a ‘sugar bank’ of carbohydrate compounds illustrate the innovation of a Chinese pharmaceutical company.